1. Acute and Late Toxicity after Three-Dimensional Conformal Image-Guided Radiotherapy for Localized Prostate Cancer
- Author
-
Rosaria Barbarino, Alessandra Carosi, Riccardo Santoni, Alessandra Murgia, Gianluca Ingrosso, Michaela Benassi, Pierluigi Bove, Elisabetta Ponti, Luana Di Murro, Emilia Giudice, and Daniela di Cristino
- Subjects
Male ,Bladder & prostate cancer ,Oncology ,Imaging ,Late effects of therapy ,Cancer Research ,medicine.medical_specialty ,medicine.medical_treatment ,Aged ,Aged, 80 and over ,Cone-Beam Computed Tomography ,Disease-Free Survival ,Dose Fractionation ,Humans ,Middle Aged ,Prostatic Neoplasms ,Radiotherapy, Conformal ,Radiotherapy, Image-Guided ,Treatment Outcome ,Image guided radiotherapy ,Late toxicity ,Prostate cancer ,Settore MED/36 - Diagnostica per Immagini e Radioterapia ,Internal medicine ,80 and over ,Medicine ,Radiotherapy ,Conformal ,Genitourinary system ,business.industry ,General Medicine ,prostate cancer ,Tumor control ,medicine.disease ,Radiation therapy ,Bladder & ,Image-Guided ,Total dose ,Toxicity ,Dose Fractionation, Radiation ,Radiology ,business - Abstract
We evaluated the clinical impact of a high definition micro-multileaf collimator and a linac-integrated cone-beam computed tomography in 142 patients treated with conformal radiotherapy for localized prostate cancer to a total dose of 76 Gy. Details on treatment toxicity and tumour control were collected. The 3 years biochemical relapse-free survival was 90%. Acute and late gastrointestinal toxicities were low (3-year actuarial late toxicity of 11.2%). Acute genitourinary toxicity was relatively high, the 3-year actuarial genitourinary late toxicity was 12%. Conformal image-guided radiotherapy for localized prostate cancer leads to low rates of late toxicity with a high rate of tumor control.
- Published
- 2014
- Full Text
- View/download PDF